AMDL Announces Investor Relations Presentation Available on Website
July 03 2008 - 6:00AM
PR Newswire (US)
TUSTIN, Calif., July 3 /PRNewswire-FirstCall/ -- AMDL, Inc.
(AMEX:ADL), a world leader in specialty pharmaceuticals
headquartered in Tustin, Ca., with operations in Shenzhen, Jiangxi,
and Jilin, China, announced today it has released its investor
presentation which is available for viewing on the Company's
website at http://www.amdl.com/. About AMDL: AMDL, Inc. is a global
specialty pharmaceutical company. The company is headquartered in
Tustin, California with operations in Shenzhen, Jiangxi, and Jilin,
China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI),
AMDL is devoted to the research, development, manufacturing, and
marketing of diagnostic, pharmaceutical, nutritional supplement,
and cosmetic products currently in China. The company employs
approximately 320 people in the U.S. and China. More information
about AMDL and its products can be obtained at
http://www.amdl.com/. About Jade Pharmaceutical: JPI has access to
the fastest growing pharmaceutical and consumer market in the
world: China. AMDL, through its subsidiaries, Jade currently
manufactures large volume injection fluids, tablets and other
related products, holding licenses for 133 products. It also
manufactures 107 generic, over the counter and supplemental
pharmaceutical products under certified Chinese Good Manufacturing
Practice (CGMP) standards. Forward-Looking Statements: This news
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Such
statements are subject to certain risks and uncertainties, and
actual circumstances, events or results may differ materially from
those projected in such forward-looking statements. The Company
cautions readers not to place undue reliance on any forward-looking
statements. The Company does not undertake, and specifically
disclaims any obligation, to update or revise such statements to
reflect new circumstances or unanticipated events as they occur.
AMDL Contact: Kristine Szarkowitz Director-Investor Relations (206)
310-5323 DATASOURCE: AMDL, Inc. CONTACT: Kristine Szarkowitz,
Director-Investor Relations, +1-206-310-5323, Web site:
http://www.amdl.com/
Copyright
Amdl (AMEX:ADL)
Historical Stock Chart
From May 2024 to Jun 2024
Amdl (AMEX:ADL)
Historical Stock Chart
From Jun 2023 to Jun 2024